"Brigid Freyne MD practices internal medicine and rheumatology in Murrieta, CA."

During the past decade, Brigid Freyne, MD Inc. conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 8 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Brigid Freyne, MD Inc." #1 sponsor was "Endo Pharmaceuticals" with 3 trials, followed by "Brigham and Women's Hospital" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Brigid Freyne, MD Inc." #1 collaborator was "Columbia University" with 1 trials as a collaborator, "Laboratory Corporation of America" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Brigid Freyne, MD Inc." are "Dupuytren's Contracture" (2 trials), "Rheumatoid Arthritis" (2 trials), "Arthritis, Rheumatoid" (1 trials), "Cardiovascular Disease" (1 trials) and "Dupuytren's Disease" (1 trials). Many other conditions were trialed in "Brigid Freyne, MD Inc." in a lesser frequency.

Most popular intervention types in "Brigid Freyne, MD Inc." are "Drug" (5 trials), "Biological" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Etanercept" (2 trials), "Methotrexate" (2 trials), "Adalimumab" (1 trials) and "Colchicine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Brigid Freyne, MD Inc." are 10 trials for "All" genders.

Currently, there are NaN active trials in "Brigid Freyne, MD Inc.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Brigid Freyne, MD Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Brigid Freyne, MD Inc., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".